James Howard

Journeys Metabolic is a Biogenerator Ventures-incubated company with a first-in-industry digital intervention platform uniquely targeting insulin resistance for chronic disease prevention and reversal. Company launched digital platform and is in process of asset sale of patient-directed prescriptive protocol.

• Personally architected value-based care platform via product development and acquisitions as first clinically-validated, EHR-interoperable solution targeting the root cause of most chronic conditions
• Designed and launched first-in-market health system standardized care pathway in primary care as bridge to outcomes-based reimbursement in multiple therapeutic areas
• Built broad food-as-medicine partnership network of funding and research collaborations including federal and state grants, multiple academic research collaborations, and pharma partnerships, including Novartis, JDRF, and Washington University in St. Louis
• Recruited top-tier provider-centric executive and advisory teams to drive innovative approach to value-based care strategy in health system and payer models
• Raised $5m in venture capital for R&D, supported by $5m in early research revenue leading to 2024 solution release
• Built organization on pillars of purpose, accountability and alignment to our mission, and inclusivity of all patient populations within unique all-stakeholder win model, working backwards from population-level care gaps in value creation

Biogenerator Ventures is the funding and incubation arm of BioSTL, the primary civic organization backed by federal grants to support St. Louis-based innovation, including Washington University School of Medicine technology transfers.

• Designed commercial strategies for portfolio teams as operating partner for portfolio in digital health and medical device segments
• Converted from EIR to founder of Readout, Inc. d/b/a Journeys Metabolic, leaving firm to manage cardiometabolic portfolio company after five months
• Supported investment team intake and diligence of digital health ventures and secondary investment, including licensing of Washington University School of Medicine technologies

SentiAR is a Biogenerator Ventures-incubated, Washington University School of Medicine spinout that developed and launched the CommandEP augmented reality imaging platform for cardiac EP ablation procedures, converting existing 2D images to 3D in-procedure holograms.

• As inaugural CEO, negotiated tech transfer from Washington University into Biogenerator incubation
• Raised initial $4m in seed capital and SBIR grants to hire initial regulatory and development teams to fuel development and clinical trial for FDA clearance as Class 2 software-as-a-medical device
• Built critical data partnerships from single high-risk dependency to multiple data options to reduce commercial and investor risk

Originating from the genomics expertise of the Human Genome Project, PierianDx was a Washington University School of Medicine tech transfer that launched a suite of novel clinical genomics sequencing software and services.

• Initial commercial executive hire, recruited team of six NGS sales and support experts to drive partner success in high-throughput genetic testing
• Built commercial partner strategy for shared oncology interpretations network that led to market leadership within six months and solution segment standard
• Signed 15 incremental high-volume academic and lab genomic data partners resulting in $12m in annual contract value as startup
• Instituted Challenger Selling approach in shared oncology interpretations of NGS

Carefusion was the 2009 technology spinout of Cardinal Health with a large suite of market-leading software and medical device solutions in the hospital market.

• Drove highest achieving unit in Pyxis organization as Director, promoted in 2013 to VP of Sales in respiratory business unit over four teams with 50 reports
• Optimized top line and margin contributions with $70m in software and hardware revenue in highly competitive segment
• Built profitable health system standardization partnerships to increase low-CAC revenue by aligning with additional business units as integrative solution approach
• Secured largest Veteran's Administrative contract in business unit history through regional selling strategy

As an early value-based care enabler, Pharmacy OneSource was a leading digital health startup with a suite of seven clinical pharmacy applications to reduce medication expense, enable antibiotic stewardship programming, and implement clinical decision support driving clinical cost reduction.

• Initial sales rep hire in 2002, promoted to VP Business Development in 2005 after securing 11 large health system clients and 240 hospital clients in the US and Asia
• Promoted to VP Commercial in 2008 after driving adoption in 20% of US hospitals with annual client renewal rate of 96%
• Drove culture-first employment model resulting as Top-10 Places to Work by Modern Healthcare in 2008, aided by 0% voluntary turnover in sales organization in five years
• Drove solution expansion strategy with OneSource bundling for average of 2.3 solutions per IDN